Financials
- Market Capitalization 1.94 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-7.9
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2000 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.99 USD | -3.80% | -1.20% | +14.54% | -15.41% | 1.96 B USD | ||
| 2008 | TYRA Tyra Biosciences, Inc. - Common Stock | 32.67 USD | -0.24% | +5.18% | +20.15% | +127.82% | 1.94 B USD | ||
| 2014 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.51 USD | +2.46% | +5.36% | +33.71% | +107.95% | 1.92 B USD | ||
| 2028 | NBTX Nanobiotix S.A. - ADSs | 39.15 USD | -2.30% | -3.69% | +5.24% | +629.05% | 1.90 B USD |